drugset / Trial / NCT06171607

Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses

NCT06171607

NaSingle-groupOpen-labelDiagnostic

Summary

This clinical trial investigates the role of contrast enhanced ultrasound (CEUS) in identifying cystic breast masses as benign or malignant. Ultrasound is a diagnostic imaging test that uses sound waves to make pictures of the body without using radiation (x-rays). Ultrasounds are widely used to diagnose many diseases in the body. This trial may help researchers learn if using CEUS will help in determining whether or not an ultrasound guided biopsy is necessary.

Timeline

Start
2020-11-05
Primary completion
2026-11-05
Completion
2027-11-05

Drugs

EvaluationDrugModalityDoseRoute
Background Definity Diagnostic / imaging agent Intravenous
Background Lumason Diagnostic / imaging agent Intravenous

Indications